Skip to main content

Peer Review reports

From: Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter study

Original Submission
18 Nov 2023 Submitted Original manuscript
20 Dec 2023 Reviewed Reviewer Report
22 Jan 2024 Reviewed Reviewer Report - Francesca Di Cosimo
6 Feb 2024 Author responded Author comments - Spilios Manolakopoulos
Resubmission - Version 2
6 Feb 2024 Submitted Manuscript version 2
8 Feb 2024 Author responded Author comments - Spilios Manolakopoulos
Resubmission - Version 3
8 Feb 2024 Submitted Manuscript version 3
10 Feb 2024 Author responded Author comments - Spilios Manolakopoulos
Resubmission - Version 4
10 Feb 2024 Submitted Manuscript version 4
12 Feb 2024 Author responded Author comments - Spilios Manolakopoulos
Resubmission - Version 5
12 Feb 2024 Submitted Manuscript version 5
20 Feb 2024 Reviewed Reviewer Report - Francesca Di Cosimo
1 Mar 2024 Author responded Author comments - Spilios Manolakopoulos
Resubmission - Version 6
1 Mar 2024 Submitted Manuscript version 6
Publishing
11 Mar 2024 Editorially accepted
12 Apr 2024 Article published 10.1186/s12876-024-03200-3

You can find further information about peer review here.

Back to article page